Relypsa, Inc. (NASDAQ:RLYP) announced the pricing of an underwritten public offering of 3,591,836 shares of its common stock at a price to the public of $24.50 per share for gross proceeds of approximately $88 million. Relypsa Inc (NASDAQ:RLYP) shares after opening at $23.93 moved to $24.48 on last trade day and at the end of the day closed at $24.05. Company price to cash ratio in past twelve months was calculated as 43.30. Relypsa Inc (NASDAQ:RLYP) showed a negative weekly performance of -11.48%.
Spherix Inc (NASDAQ:SPEX) has reportedly sued Cisco over allegations of patent infringement by Cisco of 11 patents owned by Spherix Inc, which it had acquired from Nortel Networks. Spherix Inc (NASDAQ:SPEX) shares fell -10.29% in last trading session and ended the day on $2.18. SPEX return on equity ratio is recorded as -550.40% and its return on assets is -373.10%. Spherix Inc (NASDAQ:SPEX) yearly performance is -69.85%.
MacroGenics (NASDAQ:MGNX) had its target price lifted by Stifel Nicolaus from $51.00 to $53.00 in a research note released on Friday morning, Analyst RN reports. MacroGenics Inc (NASDAQ:MGNX) shares moved down -13.24% in last trading session and was closed at $20.38 while trading in range of $19.95 – $23.49 – MacroGenics Inc (NASDAQ:MGNX) year to date (YTD) performance is -25.70%.
AngioDynamics (NASDAQ:ANGO) had its price target upped by Canaccord Genuity from $15.50 to $16.25 in a research note issued to investors on Thursday, American Banking News.com reports. AngioDynamics, Inc. (NASDAQ:ANGO) weekly performance is -10.68%. On last trading day company shares ended up $13.93. AngioDynamics, Inc. (NASDAQ:ANGO) distance from 50-day simple moving average (SMA50) is -12.13%. Analysts mean target price for the company is $18.63.